These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33140522)

  • 21. Reliability of the Charcot-Marie-Tooth functional outcome measure.
    Bray P; Cornett KMD; Estilow T; Pareyson D; Zuccarino R; Skorupinska M; Pipis M; Sowden JE; Scherer S; Reilly MM; Shy ME; Herrmann DN; Burns J; Eichinger KJ
    J Peripher Nerv Syst; 2020 Sep; 25(3):288-291. PubMed ID: 32844461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hand function and disability of the arm, shoulder and hand in Charcot-Marie-Tooth disease.
    Eklund E; Svensson E; Häger-Ross C
    Disabil Rehabil; 2009; 31(23):1955-62. PubMed ID: 19479509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale.
    Zuccarino R; Prada V; Moroni I; Pagliano E; Foscan M; Robbiano G; Pisciotta C; Cornett K; Shy R; Schenone A; Pareyson D; Shy M; Burns J
    J Peripher Nerv Syst; 2020 Jun; 25(2):138-142. PubMed ID: 32394473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children.
    Pagliano E; Moroni I; Baranello G; Magro A; Marchi A; Bulgheroni S; Ferrarin M; Pareyson D
    J Peripher Nerv Syst; 2011 Sep; 16(3):237-242. PubMed ID: 22003938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a.
    Videler AJ; van Dijk JP; Beelen A; de Visser M; Nollet F; van Schaik IN
    Neurology; 2008 Oct; 71(16):1254-60. PubMed ID: 18852440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A thumb opposition splint to improve manual dexterity and upper-limb functioning in Charcot-Marie-Tooth disease.
    Videler A; Eijffinger E; Nollet F; Beelen A
    J Rehabil Med; 2012 Mar; 44(3):249-53. PubMed ID: 22366728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease.
    Niu HX; Wang RH; Xu HL; Song B; Yang J; Shi CH; Li YS; Zhang BQ; Wang SP; Yong Q; Wang YY; Xu YM
    Chin Med J (Engl); 2017 Aug; 130(15):1773-1778. PubMed ID: 28748848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.
    Johnson NE; Heatwole C; Creigh P; McDermott MP; Dilek N; Hung M; Bounsanga J; Tang W; Shy ME; Herrmann DN
    Ann Neurol; 2018 Aug; 84(2):225-233. PubMed ID: 30014533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study.
    Prada V; Schizzi S; Poggi I; Mori L; Gemelli C; Hamedani M; Accogli S; Maggi G; Grandis M; Mancardi GL; Schenone A
    J Neurol Neurophysiol; 2018 Jul; 9(4):465. PubMed ID: 30305981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flexor digitorum superficialis opposition tendon transfer improves hand function in children with Charcot-Marie-Tooth disease: case series.
    Estilow T; Kozin SH; Glanzman AM; Burns J; Finkel RS
    Neuromuscul Disord; 2012 Dec; 22(12):1090-5. PubMed ID: 22944171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Handgrip impairment in Charcot-Marie-Tooth disease.
    Vinci P; Villa LM; Castagnoli L; Marconi C; Lattanzi A; Manini MP; Calicchio ML; Vitangeli L; Di Gianvito P; Perelli SL; Martini D
    Eura Medicophys; 2005 Jun; 41(2):131-4. PubMed ID: 16200028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice.
    Jennings MJ; Kagiava A; Vendredy L; Spaulding EL; Stavrou M; Hathazi D; Grüneboom A; De Winter V; Gess B; Schara U; Pogoryelova O; Lochmüller H; Borchers CH; Roos A; Burgess RW; Timmerman V; Kleopa KA; Horvath R
    Brain; 2022 Nov; 145(11):3999-4015. PubMed ID: 35148379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve conduction velocity in CMT1A: what else can we tell?
    Manganelli F; Pisciotta C; Reilly MM; Tozza S; Schenone A; Fabrizi GM; Cavallaro T; Vita G; Padua L; Gemignani F; Laurà M; Hughes RA; Solari A; Pareyson D; Santoro L;
    Eur J Neurol; 2016 Oct; 23(10):1566-71. PubMed ID: 27412484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The motor function measure to study limitation of activity in children and adults with Charcot-Marie-Tooth disease.
    Allard L; Rode G; Jacquin-Courtois S; Pouget MC; Rippert P; Hamroun D; Poirot I; Bérard C; Vuillerot C;
    Ann Phys Rehabil Med; 2014 Dec; 57(9-10):587-99. PubMed ID: 25311851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease.
    de França Costa IMP; Nunes PS; de Aquino Neves EL; Lima Santos Barreto LC; Garcez CA; Souza CC; Pereira Oliveira PM; Sales Ferreira LA; Brandão Lima VN; de Souza Araújo AA
    Gait Posture; 2018 May; 62():463-467. PubMed ID: 29674285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease.
    Piscosquito G; Reilly MM; Schenone A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Vita G; Quattrone A; Padua L; Gemignani F; Visioli F; Laurà M; Calabrese D; Hughes RA; Radice D; Solari A; Pareyson D; ;
    Eur J Neurol; 2015 Dec; 22(12):1556-63. PubMed ID: 26227902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charcot-Marie-Tooth Disease Type 1A: Influence of Body Mass Index on Nerve Conduction Studies and on the Charcot-Marie-Tooth Examination Score.
    Jerath NU; Shy ME
    J Clin Neurophysiol; 2017 Nov; 34(6):508-511. PubMed ID: 28914656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure.
    Mandarakas MR; Eichinger KJ; Bray P; Cornett KMD; Shy ME; Reilly MM; Ramdharry GM; Scherer SS; Pareyson D; Estilow T; McKay MJ; ; Herrmann DN; Burns J
    Neurology; 2024 Feb; 102(3):e207963. PubMed ID: 38237108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study.
    Fridman V; Sillau S; Bockhorst J; Smith K; Moroni I; Pagliano E; Pisciotta C; Piscosquito G; Laurá M; Muntoni F; Bacon C; Feely S; Grider T; Gutmann L; Shy R; Wilcox J; Herrmann DN; Li J; Ramchandren S; Sumner CJ; Lloyd TE; Day J; Siskind CE; Yum SW; Sadjadi R; Finkel RS; Scherer SS; Pareyson D; Reilly MM; Shy ME;
    Ann Neurol; 2023 Mar; 93(3):563-576. PubMed ID: 36203352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.